Although 90% of patients with rheumatic diseases have health insurance, 57.13% report struggling to afford their medication, with one-quarter paying more than $1,000 out of pocket each year for treatment, according to a survey from the American College of Rheumatology.

“These findings make clear that Americans living with rheumatic disease — regardless of age, gender or income level — struggle to find affordable care,” Paula Marchetta, MD, MBA, president of the ACR, said in a press release. “To address these challenges, it is